The results of the in-silico study showed that both compounds have the ability to bind with TMPRSS2 and ACE2, and they suppressed the infection of VeroE6 cells with SARS-CoV-2 by inhibiting the interaction between S protein and ACE2, which indicates that both compounds can be used for the treatment and prevention of SARS-CoV-2 [108]. The gene discussed is ACE2; the disease is infection.